Effect of minor populations of NS5A and NS5B resistance-associated variants on HCV genotype-3 response to daclatasvir plus sofosbuvir, with or without ribavirin. [electronic resource]
Producer: 20180326Description: 237-246 p. digitalISSN:- 2040-2058
- Alleles
- Amino Acid Substitution
- Antiviral Agents -- therapeutic use
- Carbamates
- Drug Resistance, Viral
- Drug Therapy, Combination
- Female
- Gene Frequency
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Male
- Polymorphism, Genetic
- Pyrrolidines
- Ribavirin -- therapeutic use
- Sequence Analysis, DNA
- Sofosbuvir -- therapeutic use
- Treatment Failure
- Treatment Outcome
- Valine -- analogs & derivatives
- Viral Load
- Viral Nonstructural Proteins -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.